AbbVie
ABBV
#32
Rank
โ‚ฌ297.53 B
Marketcap
168,37ย โ‚ฌ
Share price
0.26%
Change (1 day)
11.39%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - P/B ratio

P/B ratio as of January 2025 : 51.0

According to AbbVie's latest financial reports the company has a price-to-book ratio of 5.57193.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AbbVie - P/B ratio (from 2012 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3151.896.9%
2023-12-3126.359.17%
2022-12-3116.56.61%
2021-12-3115.57.36%
2020-12-3114.4-190.14%
2019-12-31-16.0-0.73%
2018-12-31-16.1-153.29%
2017-12-3130.337.99%
2016-12-3122.0-9.2%
2015-12-3124.2-59.56%
2014-12-3159.8220.35%
2013-12-3118.716.28%
2012-12-3116.0
2011-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.63-96.80%๐Ÿ‡บ๐Ÿ‡ธ USA
6.96-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
50.3-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
20.0-60.70%๐Ÿ‡บ๐Ÿ‡ธ USA
6.47-87.31%๐Ÿ‡บ๐Ÿ‡ธ USA
1.29-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
3.97-92.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.31-89.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.65-88.92%๐Ÿ‡บ๐Ÿ‡ธ USA